Charles A. Baker
Keine laufenden Positionen mehr
Profil
Charles A.
Baker served as Chairman, President & CEO of The Liposome Co., Inc. from 1989 to 2000.
He was an Independent Director at Regeneron Pharmaceuticals, Inc. from 1989 to 2018 and at Progenics Pharmaceuticals, Inc. from 2011 to 2013.
He also held Principal positions at Abbott Laboratories and Pfizer Inc. from 1994 to 2013.
Prior to his business career, he earned an undergraduate degree from Swarthmore College and a graduate degree from Columbia Law School.
Ehemalige bekannte Positionen von Charles A. Baker
| Unternehmen | Position | Ende |
|---|---|---|
| REGENERON PHARMACEUTICALS, INC. | Director/Board Member | 08.06.2018 |
| PROGENICS PHARMACEUTICALS, INC. | Director/Board Member | 12.06.2013 |
| PFIZER, INC. | Corporate Officer/Principal | 01.01.2013 |
The Liposome Co., Inc.
 The Liposome Co., Inc. Pharmaceuticals: MajorHealth Technology The Liposome Co., Inc. is a biopharmaceutical company engaged in the discovery, development, manufacturing and marketing of proprietary lipid- and liposome-based pharmaceuticals, primarily for the treatment of cancer and other related life-threatening illnesses. | Chief Executive Officer | 01.09.2000 |
| ABBOTT LABORATORIES | Corporate Officer/Principal | - |
Ausbildung von Charles A. Baker
| Swarthmore College | Undergraduate Degree |
| Columbia Law School | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| ABBOTT LABORATORIES | Health Technology |
| PFIZER, INC. | Health Technology |
| REGENERON PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
The Liposome Co., Inc.
The Liposome Co., Inc. Pharmaceuticals: MajorHealth Technology The Liposome Co., Inc. is a biopharmaceutical company engaged in the discovery, development, manufacturing and marketing of proprietary lipid- and liposome-based pharmaceuticals, primarily for the treatment of cancer and other related life-threatening illnesses. | Health Technology |
Progenics Pharmaceuticals, Inc.
 Progenics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Progenics Pharmaceuticals, Inc. engages in the development of medicines and other products for targeting and treating cancer. Its pipeline includes therapeutic agents, imaging agents for prostate cancer, and imaging analysis technology. The company was founded by Paul J. Maddon on December 1, 1986 and is headquartered in New York, NY. | Health Technology |
| Squibb Corp. | Health Technology |
